Introduction
The hepatitis C virus (HCV) is a major public health problem and one of the leading causes of chronic liver disease in the world. 1 The World Health Organization recently estimated that 130-170 million people are chronically infected with HCV and that 3-4 million people become infected with HCV each year. 2 In China, 3.2% of the population is positive for anti-HCV antibodies and about 40 million people are infected with HCV. In northeast China, 4.6% of the population is positive for anti-HCV antibodies. The prevalence of HCV infection increases with age. 3 Early detection of hepatitis C is essential to prevent the progression of hepatitis C to cirrhosis and hepatocellular carcinoma. A good understanding of hepatitis C is a prerequisite for preventing its spread and for controlling it. However, many people, including some medical practitioners, have a low level of awareness of HCV infection. In some instances, hepatitis C infection remains undetected because no symptoms are displayed. Moreover, some HCV-positive people have not been advised to seek further advice because of their medical practitioner's poor awareness of hepatitis C. Some studies reported that the majority of health professionals lack the knowledge and skills required to effectively care for people with HCV and that social prejudice towards self-reported behavior and a fear of contracting hepatitis C negatively affect their attitudes to these patients. 4, 5 DXY.cn is a professional website for biomedical technology in China and attracts visits from more than 2.4 million medical, pharmaceutical, and life science professionals per year. More than 90% of physicians younger than 45 years of age are aware of it. After the second "World Hepatitis Day", these authors used the DXY.cn website from April 15 to July 15 to determine the awareness of medical staff from nonspecialist departments (especially surgical departments) of hepatitis C.
Methods
These authors published a questionnaire on hepatitis C on www.dxy.cn on April 15, 2009. All visitors to the website could sign up and answer the questions online. Only data from nonspecialists were analyzed. The section on basic information included questions about the respondent's city, hospital level, department, and professional title. The questions are listed in Table 1 .
Results

Characteristics of respondents
About 1362 physicians from 30 provinces, autonomous regions, and municipalities in China took part in the survey. The respondents were from more than 200 cities; most respondents were from Beijing (95), followed by Shanghai (65), Wuhan (53), Guangzhou (52), and Changsha (42). Sixty percent of respondents were associated with Grade III hospitals, 28% percent with Grade II hospitals, and the remainder were associated with Grade I hospitals and community health service centers (Table 2) . These respondents were associated with 13 departments, including departments of general surgery (13%), orthopedics (12%), gastroenterology (7%), cardiology (6%), neurology (5%), gynecology and obstetrics (4%), cardiothoracic surgery (3%), ophthalmology and ear-nose and throat (4%), and the remainder (46%) were associated with departments other than infectious disease and hepatology departments (Table 2 ). It should be noted that hepatitis C is treated in hepatology or infectious disease departments rather than in a department of gastroenterology in China. Forty-nine percent of respondents were resident physicians, 27% were attending physicians, 10% were associate chief physicians or chief physicians, and 14% had other titles ( Table 2) .
Awareness of HCV transmission
In response to the question "Which is not a transmission route for hepatitis C?" 89% of respondents thought that hepatitis C was Notes: *According to the "rules to be in charge of hospitals by grade," hospital grade is a comprehensive indicator that reflects a hospital's scale and technical proficiency in China. Grade III hospitals are the largest, most resource-intensive, and most proficient; **Other includes all clinical departments except the eight listed above. Data for these departments were pooled because each constituted less than 3% of the total number of respondents. Thirty-eight percent of respondents regarded anti-HCV antibody detection as a routine examination in hospital, 42% tested a patient for HCV before performing an invasive operation, and 6% tested for HCV at the patient's request. Only 5% of the respondents tested themselves for anti-HCV antibodies when they were accidentally injured at the hospital. not transmitted by kissing, hugging, or sharing eating utensils. However, 11% of the clinical practitioners mistakenly believed that the disease was not transmitted from mother to infant, by sharing a needle or syringe, by sharing a razor or toothbrush, or by having sex with a partner with HCV infection (Figure 1 ).
Awareness of HCV detection measures
Thirty-eight percent of respondents considered anti-HCV antibody detection a routine examination in hospitals, 42% tested patients for HCV before performing invasive operations, and 6% tested for HCV at the patient's request. Only 5% of respondents tested themselves for HCV when they were accidentally injured at the hospital ( Figure 2 ) and 8% thought that the anti-HCV antibody was a protective antibody ( Figure 3 ).
Attitude of respondents to patients with HCV
The majority of nonspecialists were aware of the dangers of hepatitis C. Seventy-six percent knew that hepatitis C causes liver cirrhosis and hepatocellular carcinoma. When presented with a positive test result for HCV for one of their patients, 56% of the respondents indicated that they referred such patients to a specialist, 13% informed the patients themselves, and 20% informed the appropriate department at the hospital. Additionally, 5% of the respondents took measures Figure 5 Attitude of the respondents to anti-hepatitis C virus-positive patients without clinical manifestations or elevated alanine aminotransferase levels. Of the respondents, 74% indicated that they would definitely refer the patients to a specialist, 11% would occasionally refer a patient to a specialist, and 12% gave no advice. Awareness of the respondents of hepatitis C treatment. Of the respondents, 71% thought that hepatitis C was incurable or had a very low cure rate, 14% did not understand the treatment of hepatitis C, and only 15% knew that it has a high cure rate. to increase their personal protection against infection when dealing with such patients and 6% took no additional protective measures (Figure 4 ).
If a patient had no clinical symptoms but was positive for HCV and had normal liver function, 74% of the respondents indicated that they would refer the patient to a specialist, 11% indicated that they would occasionally refer such patients to a specialist, and 12% would take no action ( Figure 5 ).
Awareness of hepatitis C treatment
Seventy-one percent of respondents thought that hepatitis C is incurable or has a very low rate of cure, 14% did not know how to treat hepatitis C, and only 15% knew that the rate of cure of hepatitis C is high ( Figure 6 ).
Thirty-seven percent thought that there is no such thing as a carrier of HCV and that patients with HCV should be treated. Nearly 50% thought there are no effective treatments for hepatitis C (Figure 3 ).
Discussion
Because of the decrease in the prevalence of hepatitis B as a result of widespread use of the hepatitis B vaccine, hepatitis C has attracted increasing attention in recent years. The degree to which the public and medical staff understands hepatitis C is important for the prevention and treatment of hepatitis C. This investigation was conducted to investigate the awareness of hepatitis C of nonspecialist physicians.
Of the clinical practitioners surveyed, 11% did not understand the transmission routes of hepatitis C. They were not aware that HCV is transmitted from mother to infant, by sharing a needle or syringe, by sharing a razor or toothbrush, or by having sex with a partner with HCV infection. When asked how hepatitis C infection could be prevented, 33% mistakenly believed that it could not be prevented by strict selection of blood donors, by promoting single-use syringes, by sterilizing medical apparatus and instruments, by wearing gloves when in contact with patients' body fluids, or by not sharing a razor or a toothbrush with a patient. The primary source of HCV transmission is HCV-infected blood and blood products. Injection of drugs is an important mode submit your manuscript | www.dovepress.com
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of transmission in some regions, and other potential sources of HCV transmission include exposure to an infected sexual partner or multiple sexual partners and frequent exposure to infected blood. Practices such as folk medicine, body piercing, tattooing, and even commercial barbering have been suggested as routes of HCV transmission. 6 Knowledge of probable transmission routes is essential for the prevention of hepatitis C.
Two classes of assays are used in the diagnosis of HCV infection: anti-HCV antibody detection and HCV ribonucleic acid detection. Anti-HCV antibody detection is used to screen for and to diagnose HCV infection. Compared with HCV ribonucleic acid detection, anti-HCV antibody detection is more appropriate for medical institutions. The specificity of current enzyme immunoassays for anti-HCV antibody detection is greater than 99%. 7 In this survey, 62% of respondents did not think that anti-HCV antibody detection should be a routine analysis for patients in hospital. Additionally, in most patients, the manifestation of HCV infection is absent or mild. It is reasonable to assume that few patients with HCV infection are identified in clinical practices.
Nearly 50% of the respondents did not refer patients who were positive for HCV to a specialist for treatment. When confronted with a patient with no clinical symptoms who is positive for HCV and has normal liver function, 12% of respondents indicated that they would offer no advice. In reality, 55%-85% of people with acute hepatitis C will develop chronic hepatitis C. 8, 9 Of such individuals, 5%-20% will develop cirrhosis over a period of 20-25 years. 10 Persons with HCV-related cirrhosis are at risk of developing end-stage liver disease as well as hepatocellular carcinoma. Clinical practitioners should take the following actions when it becomes apparent that a patient is positive for HCV: refer the patient to a specialist for further diagnosis and treatment, counsel the patient regarding prevention of the spread of HCV to others, inform the appropriate departments (eg, the infection management division of the hospital and the center for disease control), and increase personal protection against infection.
Only 15% of respondents knew that hepatitis C had a high cure rate and 85% had no knowledge of the efficacy of hepatitis C therapy. Nearly 50% thought that there were no effective hepatitis C treatments. In reality, treatment of hepatitis C patients can prevent complications associated with HCV infection. Infection is considered eradicated when there is a sustained virologic response (SVR), defined as the absence of HCV ribonucleic acid in serum according to a sensitive test at the end of treatment and 6 months thereafter. There have been substantial improvements in the success rate of HCV treatment. The highest overall SVR rates (54%-56%) were achieved with a combination of weekly subcutaneous injections of long-acting pegylated interferon alfa and oral ribavirin, which represents the current standard of care. A recent large multicenter, multinational trial reported an SVR rate of 76% for patients with genotype 2 or 3 infections.
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Chinese Center for Disease Control and Prevention statistics show that the number of newly reported cases of hepatitis C is increasing every year. Between 2003 and 2008, the number of hepatitis C cases in China increased nearly fivefold to 110,000. 12 At the same time, the proportion of HCV-caused hepatocellular carcinoma patients increased. Hepatitis C infection confers a heavy emotional and economic burden on patients, families, and society, and is a public health problem. It is the common responsibility of all medical staff to prevent and treat hepatitis C. Medical practitioners should be well informed about hepatitis C and actively publicize information about hepatitis C among the public. Implementation of prevention and treatment strategies based on early discovery, diagnosis, and treatment of hepatitis C is essential for curbing the spread of hepatitis C and reducing its incidence.
Conclusion
This survey involved 1362 physicians from various regions, hospitals, and departments in China. It showed that nonspecialists have little understanding of the etiology, epidemiology, diagnosis, treatment, or prevention of hepatitis C, which may have a negative effect on the prevention and treatment of hepatitis C. To reverse this situation, medical institutions at all levels, especially the Chinese Center for Disease Control and Prevention, the Chinese Foundation for Hepatitis Prevention and Control, and the Chinese Society of Hepatology, should vigorously promote basic knowledge about hepatitis C, and nonspecialists should undergo continuous medical education on hepatitis C. It is also important for nonspecialists to learn through interaction with specialists.
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